Trials / Unknown
UnknownNCT06199908
AMT-562 in Patients With Selected Advanced Solid Tumors
First-in-Human, Phase 1 Study of AMT-562 in Patients With Advanced Solid Tumors
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 72 (estimated)
- Sponsor
- Multitude Therapeutics (Australia) Pty Ltd · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a first-in-human, non-randomized, open-label, multicenter Phase 1 study of AMT-562 in patients with advanced solid tumors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AMT-562 | Administered AMT-562 for injection intravenously |
Timeline
- Start date
- 2024-05-20
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
- First posted
- 2024-01-10
- Last updated
- 2024-07-26
Locations
2 sites across 1 country: Australia
Source: ClinicalTrials.gov record NCT06199908. Inclusion in this directory is not an endorsement.